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We have developed an optical system based on visible light spectroscopy for the continuous study of changes in the redox states of
mitochondrial cytochromes in intact mammalian cells. Cells are suspended in a closed incubation chamber in which oxygen and nitric oxide
(NO) concentrations can be monitored during respiration. Simultaneously the cells are illuminated with a broad-band tungsten–halogen light
source. Emergent light in the visible region (from 490–650 nm) is detected using a spectrophotometer and charge-coupled device camera
system. Intensity spectra are then converted into changes in optical attenuation from a ‘steady-state’ baseline. The oxidised-minus-reduced
absorption spectra of the mitochondrial cytochromes are fitted to the attenuation spectra using a multi-wavelength least-squares algorithm.
Thus, the system can measure changes in the redox states of the cytochromes during cellular respiration. Here we describe this novel
methodology and demonstrate its validity by monitoring the action of known respiratory chain inhibitors, including the endogenous
signalling molecule NO, on cytochrome redox states in human leukocytes.
D 2003 Elsevier B.V. All rights reserved.Keywords: Visible light spectroscopy; Cellular respiration; Cytochrome redox state; Mitochondrial inhibitor; Nitric oxide1. Introduction
Optical spectroscopy has for many years been employed
as a research tool for studying the composition and function
of biological tissues both in vitro and in vivo (for review see
Ref. [1]). The majority of in vivo studies have exploited the
oxygen-dependence of light absorption by chromophores
such as haemoglobin [2], myoglobin [3] and cytochrome c
oxidase [4,5] to monitor oxygen (O2) delivery and con-
sumption in tissue. Spectroscopic studies of in vitro systems
have focused on events involving O2 utilisation in isolated
cytochrome c oxidase [6,7], via the electron transport chain
(ETC) in mitochondria [8–10] and, to a lesser extent, in
whole cells [11,12].
The capacity of the signalling molecule nitric oxide
(NO) to modulate respiration through the reversible inhi-0005-2728/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2003.09.012
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0470.
E-mail address: s.moncada@ucl.ac.uk (S. Moncada).bition of cytochrome c oxidase (complex IV) has previ-
ously been demonstrated in mammalian mitochondria
using visible spectroscopy [13]. The extent of inhibition
is known to be dependent on O2 concentration due to a
competition between NO and O2 for the haem a3/CuB
binding site of cytochrome c oxidase, with a half-inhibition
for respiration of 60 and 250 nM of NO at O2 concen-
trations of 30 and 145 AM, respectively [14]. Under
physiological conditions, O2 tensions of 34.8F 6.9 mm
Hg (43.5F 8.9 AM) for terminal arterioles and 23.5F 5.3
mm Hg (29.4F 6.6 AM) for tissue have been observed
[15]. Hence, in vivo concentrations of O2 are such that the
nanomolar concentrations of NO present in tissues [16]
could potentially modulate the affinity of cytochrome c
oxidase for O2 under physiological conditions. Studies
have in fact shown that NO from vascular endothelial
cells, under basal and stimulated conditions, modulates the
respiration of these cells in an O2-dependent manner [17].
However, these effects of NO have not previously been
studied by following the redox states of the ETC cyto-
chromes in an intact cell system.
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spectroscopy (VLS) that can monitor changes in the redox
states of mitochondrial cytochromes of mammalian cells
during respiration and hence, the effects of endogenous NO
on cellular respiratory parameters. Various limitations of
measuring cellular respiratory parameters in a closed system
such as the one described here have been pointed out [18],
including errors due to the time response of the O2 electrode
and back-diffusion of O2 into the system at low partial
pressures of O2. In our system, corrections for both the time
response of the O2 electrode as well as back-diffusion have
been systematically applied. Changes in cytochrome redox
states are determined by multi-wavelength least-squares
fitting of pure absorption spectra, measured previously on
the isolated enzymes, to attenuation changes measured in
the cells in the range 530–615 nm. In order to validate the
response of the system we have treated the Jurkat cell line of
human leukocytes with a variety of known mitochondrial
inhibitors, namely rotenone (an inhibitor of complex I),
antimycin A and myxothiazol (complex III) and potassium
cyanide (complex IV). Furthermore, we have monitored the
effects of the inhibitor NO, generated by an NO donor, on
the cytochrome redox states. These studies demonstrate the
ability of the technique to separate out redox changes in
individual cytochromes due to inhibition at different stages
of the ETC during cellular respiration.2. Materials and methods
2.1. Instrumentation
A diagrammatic representation of the VLS system is
shown in Fig. 1. Cells are placed into a glass incubation
chamber (Rank Bros., Cambridge, UK) maintained at 37
jC. O2 concentration ([O2]) within the chamber is moni-Fig. 1. Schematic diagram of the VLS system. The cells are suspended in an
incubation chamber with an O2 electrode at the base and sealed from the
atmosphere by insertion of a plunger. The plunger contains an NO electrode
probe and two optical fibres which carry light to and from the sample.tored by a Clark-type O2 electrode (Rank Bros.), the calib-
ration and measurement corrections of which are described
in Section 2.2. As shown in Fig. 1, a plunger is inserted
into the top of the chamber during respiration studies in
order to seal the sample from the atmosphere. The plunger
supports two 1-mm-diameter optical fibres (aligned parallel
to one another and separated by 3.2 mm) and an additional
electrode for monitoring NO (ISO-NOP World Precision
Instruments, Stevenage, UK). The NO electrode is cali-
brated based on a reaction in which a known amount of
nitrite is reduced to produce a known amount of NO. The
response of the NO electrode, i.e. the current produced for
a given NO concentration, was on average 2 pAnM 1
calculated from four to six additions of 1 nmol of nitrite
per calibration.
The cells are illuminated with a broad-band tungsten–
halogen light source (77501 LOT Oriel, UK), filtered by a
blue-green bandpass filter (038FG11-25 LOT-Oriel, 50%
short wavelength cut-off 350 nm) and an infrared blocker to
reduce stray light and remove unwanted heating effects
(100FL07-25 LOT-Oriel, 50% long wavelength cut-off
1000 nm). The light back-scattered from the cell suspension
is delivered to a spectrophotometer (270M Instruments SA,
USA) by the detecting fibre. All experiments were per-
formed in a dark room to minimise the amount of ambient
light reaching the spectrophotometer. Light entering the
spectrophotometer is dispersed by a 600 linesmm 1 dif-
fraction grating such that wavelengths in the visible region
of 490–650 nm (calibrated against mercury emission lines)
are incident upon a charge-coupled device (CCD) camera
(Wright Instruments, Enfield UK). The spectral resolution of
the spectrophotometer, with the entrance slit width set to
200 Am, is 1.25 nm. The spectrophotometer and CCD
camera are connected to an IBM-compatible computer and
controlled by custom-written software developed at UCL.
Spectra are acquired at a rate of 50 Hz (every 20 ms) and
averaged over a period of 500 ms (to improve signal-to-
noise ratio) such that data are recorded at a sampling rate of
2 Hz. The output of the NO electrode is input to an
analogue-to-digital converter (World Precision Instruments)
and sampled simultaneously with the spectral data by the
acquisition software.
2.2. [O2] calibration and measurement corrections
The Clark-type O2 electrode is capable of measuring a
current that is proportional to the partial pressure of O2
(PO2) in the sample. The current is converted to a voltage
and input to the analogue-to-digital converter, which is
again sampled at a rate of 2 Hz by the acquisition software.
The software converts the measured voltage to [O2] using
values determined from the calibration procedure described
below. The rate of O2 consumption (VO2) in the chamber is
also calculated on-line from the differential of [O2] with
respect to time, determined from a 20-data-point fourth-
order polynomial (i.e. fitting over a period of 10 s).
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involves a two-point calibration procedure, performed daily
in 1 ml of the medium the cells are suspended in during their
subsequent measurement in the chamber. This comprises
phenol-red-free RPMI-1640 medium (Life Technologies,
Paisley, UK), with 1% foetal bovine serum (FBS), 20 mM
glucose, 2 mM glutamine, 100 Uml 1 penicillin, 100
Agml 1 streptomycin and 25 mM HEPES buffer. With
the chamber open to the environment, O2 in the medium is
allowed to equilibrate with the surroundings until it reaches
ambient PO2, approximately 159 mm Hg. The zero point is
achieved by adding an excess of sodium dithionite
(Na2S2O4) to reduce O2 completely and then isolating the
system by insertion of the plunger. The calibration takes into
account sample temperature and salinity, ambient baromet-
ric pressure and water vapour pressure, all of which will
affect the solubility and hence concentration of O2 dissolved
in a given sample [19]. The salinity correction is based on
the concentration of NaCl, the dominant salt by an order of
magnitude, in the medium described above. At a barometric
pressure of 760 mm Hg, for example, [O2] in the medium is
calculated to be 201.9 AM at 37 jC. [O2] is assumed to vary
linearly with voltage between the ambient and zero points.
Due to the finite time taken for O2 to diffuse across the
membrane, the signal response of the Clark electrode to a
step change in PO2 (or [O2]) is not immediate. The response
can be approximated by a mono-exponential function with
time [20], characterised by the time constant s of the
electrode response. From a step change in [O2] from
ambient, induced by the addition of Na2S2O4, the time
constant of the electrode was determined to be 7.7F 0.8 s
(n = 5) at 37 jC. The time constant is then used to make a
first-order correction of the measured O2 signal for the finite
response time of the electrode [20]
½O2corr ¼ ½O2meas þ
1
s
d½O2meas
dt
ð1Þ
where [O2]corr is the time response-corrected O2 concen-
tration, [O2]meas is the measured O2 concentration and
d[O2]meas/dt is the differential of the measured concentration
with respect to time. This correction procedure has been
used by others [18,21] and its comparison with uncorrected
measurements is shown elsewhere [22].
In the absence of cells there exists a measurable back-
ground O2 flux inside the sealed chamber that is a combi-
nation of two opposing effects: (1) consumption of O2 by
the electrode itself, as a consequence of O2 reduction at the
cathode, and (2) back-diffusion, a leakage of O2 back into
the chamber at low PO2 from sources such as the plunger or
the electrolyte solution beneath the membrane. The first
effect is more significant at high PO2, whereas the second
dominates at low PO2. Since these effects will also occur in
the presence of cells, the measured VO2 must be corrected to
account for them, in order to determine the O2 consumption
due to the cells alone. The procedure for measuring thebackground O2 flux in a closed Clark-type electrode has
been extensively described by Gnaiger and colleagues
[18,22]. In our system the regression parameters for a linear
fit of O2 concentration against O2 flux were found to be
0.010F 0.004 min 1 and  0.63F 0.78 AMmin 1 for the
slope and offset, respectively. The O2 consumption due to
the cells is then determined by subtracting the background
flux from the consumption measured in the presence of cells
ðVO2Þcorr ¼ 
d½O2corr
dt
 ða0 þ a1½O2corrÞ ð2Þ
where (VO2)corr is the corrected O2 consumption by the cells,
[O2]corr is the time response-corrected O2 concentration,
defined in Eq. (1), d[O2]corr/dt is its derivative with respect
to time, and a0 and a1 are the slope and offset, respectively,
found from the linear regression of background O2 flux
against concentration. All [O2] and VO2 values given in the
results refer to the corrected values [O2]corr and (VO2)corr,
respectively.
2.3. VLS algorithm
The attenuation A of a sample is defined as the log ratio
of incident to emergent light
A ¼ log10
I0
IS
 
ð3Þ
where I0 is the intensity of the light incident on the sample
and IS is the intensity of the emergent light. In a non-
scattering sample, attenuation is a linear function of absorp-
tion and hence chromophore concentration, as described by
the Beer–Lambert Law. In a scattering sample such as cells,
however, multiple pathlengths render application of the
Beer–Lambert relation invalid and attenuation is a nonlin-
ear function of both light scattering and absorption. To
account for the nonlinearity between attenuation and ab-
sorption, the following approximation may be made: if
changes in absorption and scattering give rise to a small
change in attenuation, then that change in attenuation at any
wavelength k can be given by
DAðkÞ ¼ BA
Bla
DlaðkÞ þ
BA
Bls
DlsðkÞ ð4Þ
where la is the absorption coefficient, ls is the scattering
coefficient and Dla(k) and ls(k) are changes in the absorp-
tion and scattering coefficients, respectively. This is well
approximated by our experimental situation, since changes
in the redox states of the cytochromes induce relatively
small changes in absorption (and hence attenuation) com-
pared to the degree of nonlinearity between attenuation and
absorption [23]. Moreover, if scattering changes are zero or
negligible, the second term on the right-hand side of Eq. (4)
can be ignored and a linear relationship between changes in
attenuation and absorption exists where the constant of
proportionality, the term BA/Bla, is known as the differential
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b(k) represents the (weighted) mean path the light travels
through the scattering sample at a given wavelength k [24].
In this regime, changes in attenuation can be related to
changes in chromophore concentration by
DAðkÞ ¼ bðkÞ
Xn
i
eiðkÞDci ð5Þ
where ei is the specific absorption coefficient and Dci is the
change in the concentration of the ith chromophore, respec-
tively. Our experiments indicate negligible changes in light
scattering during cellular respiration (see further discussion
in Section 3.2), thus validating the use of Eq. (5) for
calculating changes in chromophore concentrations. The
algorithm described here for determining cytochrome redox
changes is thus based on changes in attenuation from an
initial reference, i.e. the first measurement in time. The
change in attenuation DA at any subsequent time t is
determined from experimental measurements by
DAðtÞ ¼ log10
ISð0Þ
ISðtÞ
 
ð6Þ
where IS(0) is the initial intensity emerging from the sample
at time t = 0 and IS(t) is the intensity recorded at time t.
The specific absorption spectra for cytochromes bH, c and
aa3 are displayed in Fig. 2. The spectra in fact represent the
difference in absorption between the oxidised and reduced
forms of the cytochromes. The cytochrome bH difference
absorption spectrum was measured using bovine bc1 com-
plex (complex III) [25] and represents the high potential
haem bH (b562) of cytochrome b. Although bH is only one of
the b-type haems that constitute cytochrome b of the bc1Fig. 2. Specific difference absorption spectra of cytochromes in the range
500–650 nm. These are the oxidised-minus-reduced absorption spectra of
cytochromes bH (dotted line), c (solid black line) and aa3 (solid grey line),
measured in the isolated enzymes.complex, we refer to it as cytochrome bH to be consistent
with the references to measurement of cytochromes c and
aa3. The redox state of the other b-type haem belonging to
cytochrome b, bL (b566), is assumed unchanged under O2-
limiting conditions, due to its low redox midpoint potential
in relation to bH [25]. The cytochrome c difference spectrum
was measured previously at UCL using bovine cytochrome
c, oxidised with a small amount of cytochrome c oxidase
then reduced with Na2S2O4. Changes in the redox state of
cytochrome c will also contain contributions from the c1
cytochrome of the bc1 complex, since their absorption
spectra are very similar in this region and cannot easily be
resolved. However, the two cytochromes exist in rapid
equilibrium, their redox potential mid-points separated by
only 5 mV [26]. The ratio of cytochromes c to c1 is reported
to be approximately 2.8:1 in rat liver mitochondria [27]. The
aa3 (complex IV) spectrum was measured using bovine
mitochondria [28] and represents the difference spectrum
of a combination of the a and a3 cytochromes which
comprise the cytochrome c oxidase enzyme. In this wave-
length range the spectrum contains a much greater contri-
bution from cytochrome a (80–90%) than from cytochrome
a3 [10]. Thus, redox changes determined from the difference
spectrum used here give an indirect measure of redox events
at the cytochrome c oxidase oxygen binding site, the haem
a3/CuB binuclear centre.
Fitting with the difference spectra shown in Fig. 2 yields
changes in concentration of the difference species, as
opposed to changes in absolute concentrations of the oxi-
dised and reduced forms. An increase in the oxidised-minus-
reduced absorption indicates that the cytochrome has be-
come more oxidised (assuming that the total concentration
remains the same and oxidation occurs at the expense of the
reduction) and a decrease means it has been reduced. The
acquisition software uses a linear least-squares routine to fit
the absorption spectra to the difference attenuation data
using Eq. (5). For cytochromes bH and c, a fit is performed
to the region 530–580 nm, whereas for cytochromes aa3 the
fit is in the range 590–615 nm. The two fits also include a
constant background, i.e. a flat spectrum, to account for
potential changes in attenuation that are independent of the
cytochrome redox states. For each chromophore the regres-
sion parameter of the fit is the product of the change in
concentration of the oxidised-minus-reduced form and the
pathlength b through the cell sample, hence the change in
concentration Dc is recovered by dividing the regression
parameter by the pathlength. Fig. 3 shows the two fits
described above to a difference attenuation spectrum mea-
sured at anoxia, when the cytochromes have become re-
duced. The cytochrome difference absorption peaks can be
seen at approximately 550, 560 and 605 nm, due to an
increase in the reduced form of cytochromes c, bH and aa3,
respectively. Since the redox changes are occurring from a
steady-state baseline of zero, the reduction in the cyto-
chromes means the peaks are reversed in sign relative to
the oxidised-minus-reduced spectra displayed in Fig. 2.
Fig. 3. Measured difference attenuation and spectral fits at anoxia. A
difference attenuation spectrum measured at anoxia is displayed (grey line)
with the corresponding fits for cytochromes bH and c (530–580 nm) and
aa3 (590–615nm) (black lines).
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Jurkat cells (human leukocytes) were purchased from
American Type Culture Collection (TIB 71; Manassas,
VA). Cells were cultured in suspension in a glass stirrer
bottle in RPMI-1640 with 25 mM HEPES, supplemented
with 10% FBS, 2 mM glutamine, 100 Uml 1 penicillin and
100 Agml 1 streptomycin. The cells were maintained as a
stirred culture at 37 jC in a humidified incubator containing
5% CO2 in air. Cells were harvested by centrifugation at
400	 g at room temperature, washed once with the complete
medium and resuspended in medium without phenol red dye
(to avoid interference with the optical technique) containing
1% FBS (and other components mentioned in Section 2.2) to
a final concentration of 2–3	 107 cellsml 1. Cell counting
and determination of viability at this point was carried out
using the Trypan blue exclusion method and only batches of
cells with a viability above 95% were used.
2.5. Protocol
After harvesting, cells were placed into a 50-ml Falcon
tube and incubated at 37 jC in a water bath for 40–60 min
prior to measurement, gently resuspending every 15–20
min. At the time of measurement 1 ml of cells was placed
into the respiration chamber and kept in suspension by
stirring with a magnetic glass bar at 750 rpm, sealing the
cells from the atmosphere with the plunger. At the end of
each experiment, the cells were collected from the chamber
and placed on ice for further determination of cell number.
2.6. Cell counting
In order to quantify the cell density of each individual
sample taken from the pool, a further procedure wasperformed. After each experimental measurement in the
incubation chamber, six aliquots of 100 Al from the 1-ml
sample were centrifuged and the pellets kept at  20 jC.
Cell pellets were later dissociated by 100 Al of 10% sodium
dodecylsulfate (SDS) for 20 min and diluted to a final
concentration of 2% SDS. A protein assay kit (Pierce,
USA) based on the reaction with bicinchoninic acid
(BCA) was developed in a 96-well plate, using cell con-
centrations from 0.2 to 2	 105 cells per well (2–20 Ag
proteinml 1) to obtain a standard linear regression curve
and a sample volume of 20 Al per well [29].
2.7. Cell viability
In several independent tests it was observed that the
viability of cells incubated at 37 jC remained above 95%
over a post-harvest period of 3–4.5 h, as determined by
the Trypan blue exclusion method. Cell viability was also
examined by flow cytometry at 4 h post-harvest. Aliquots
of approximately 106 cells in 1 ml of PBS, with 1% FBS
and 0.02 AM propidium iodide, were analysed by flow
cytometry on a FACScan instrument (Becton Dickinson).
Dead cells were distinguished from live cells by measur-
ing forward-angle light scattering versus fluorescence
intensity. For each sample, 105 cells were counted by
the software (CELLQUEST) to express viability, which
again remained above 95%.3. Results
3.1. Pathlength measurement
To obtain changes in chromophore concentrations using
Eq. (5), the pathlength b(k) in the scattering sample must
first be determined. Furthermore, because the fitting of the
absorption spectra extends over a range of wavelengths, the
wavelength-dependence of the pathlength (WDPL) should
also be considered. The WDPL was initially measured in the
range 490–650 nm, the range within which the fits are
performed, by adding a small amount of absorbing dye to
the cell sample. The consequent change in attenuation DA
was then divided by the specific absorption spectrum of the
dye at each wavelength, yielding the pathlength b scaled by
the change in concentration Dc. The WDPL was then found
by normalising to unity at a given wavelength. This proce-
dure was performed for cell concentrations in the range
1.6–4.9	 107 cellsml 1 (n = 10), which encompasses the
range used in subsequent experiments. The spectrophotom-
eter was then re-calibrated to the range 620–775 nm in
order to obtain the absolute pathlength b by the second
derivative method, using the spectral features of water
absorption at 740 nm [23]. The WDPL measurement was
repeated as described above for the new range, for cell
concentrations between 1.7 and 4.3	 107 cellsml 1
(n = 10). Between the wavelengths of 740 nm (the value
V.S. Hollis et al. / Biochimica et Biophysica Acta 1607 (2003) 191–202196around which the absolute pathlength was determined) and
530 nm (where the spectral fitting begins), the WDPL, and
hence the absolute pathlength, varies by less than 4%
(3.3F 2.9%). Thus, the pathlength determined at 740 nm
can be used to represent the pathlength over the entire
wavelength range, without correcting for the WDPL.
The absolute pathlength was determined by fitting the
second derivative of the water absorption spectrum to that of
the absolute attenuation spectra of the cells (referenced to
air) in the range 700–770 nm [23]. The second derivative
method approximates a linear relationship between the
second differential of attenuation (with respect to wave-
length) and the second differential of absorption via the
differential pathlength, then determines the pathlength by
assuming a water concentration of 100% for the cell
suspension. The pathlength was measured over a wide range
of cell concentrations from 1.3 to 10.5	 107 cellsml 1.
Within the range 1.5–4.5	 107 cellsml 1 the pathlength
was found to be very similar, with a mean of 2.3F 0.1 cmFig. 4. Changes in cytochrome concentrations during cellular respiration under nor
squares) and aa3 (closed triangles) are displayed (mean cell concentration is 2.6F
(closed diamonds) for the same cells is displayed against time (C) and [O2] (D).(n = 11). This value was then used in the fitting routine to
determine the redox-dependent changes in cytochrome con-
centrations, as described below. Above 4.5	 107 cellsml 1
the pathlength decreased with cell concentration. This is most
likely attributable to a decrease in the component of the
pathlength due to reflections from the base of the chamber as
cell density increases.
3.2. Control experiments
Control experiments were performed in order to charac-
terise cellular respiration under ‘normal’ conditions, i.e. in
the absence of mitochondrial inhibitors. Fig. 4 shows typical
traces of cytochromes bH, c and aa3 against time and [O2]
(Fig. 4A and B, respectively) and the corresponding VO2
(Fig. 4C and D, respectively), during respiration to anoxia.
The term ‘anoxia’ as opposed to ‘hypoxia’ is used to
describe the minimum [O2] reached, although it should be
noted that [O2] will never truly reach zero due to themal conditions. Typical changes in cytochromes bH (closed circles), c (open
0.2	 107 cellsml 1) against time (A) and [O2] (B). The corresponding VO2
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ability of the VLS method to determine changes in cyto-
chrome concentrations relies on the validity of the assump-
tion that attenuation changes are due to changes in
absorption only. It has been noted that light scattering
changes can occur due to osmotic swelling of mitochondria
on cessation of respiration [30]. In response to a 20-min
period of hypoxia (f 25 AM O2), Kreisman and LaManna
[31] reported a decrease in light intensity of approximately
26% (a change in attenuation of f 130 mOD) in rat brain
tissues. They attributed this change to cell swelling upon
hypoxia and determined its time constant to be approxi-
mately 6 min. Changes in the baseline of our measured
attenuation spectra, as indicated by the flat offsets included
in the spectral fitting, were of the order of 1 mOD and did
not occur as a direct result of reduction in the cytochromes.
We therefore conclude that scattering changes, if present,
are negligible during the time frame of our experiments
(f 5 min total, < 1 min at anoxia).
In the intact cell the P50 for cellular respiration has been
defined as the PO2 at which VO2 reaches 50% of its maximal
rate [9,18]. This parameter has been used to estimate an
apparent O2 affinity by analogy with the Michaelis–Menton
constant (Km) for O2, and has been determined using a
hyperbolic function to describe the relationship between
[O2] and VO2 [9]. However, it has been noted (as was our
experience) that the value of P50 depends strongly on the
[O2] range used in the hyperbolic fitting [18]. Hence we
determine the P50 by simple bi-linear interpolation between
data points at half-maximal VO2. We have also used the term
P50 to define the [O2] at which the reduction of each
cytochrome is half-maximal. Note that whilst P50 refers to
a partial pressure of O2, we have expressed it in terms of
concentration for consistency.
The parameters reported here for cellular respiration
under normal conditions (see Table 1) have been determined
for a cell concentration of 2.6F 0.2	 107 cellsml 1
(n = 16), measured over 5 (non-consecutive) days. The
average maximal VO2 was determined to be 30.0F 2.7
AMmin 1, i.e. a value of 11.5F 1.0 AMmin 1 per 107
cells. For comparison, Beltran et al. [32] observed an
average (uncorrected) VO2 for Jurkat cells of 12.8F 1.4
AMmin 1 per 107 cells under similar cell culture and
experimental conditions. We determined the P50 for VO2 to
be 2.3F 0.4 AM O2 (n = 16), similar to the value obtained
by Rumsey et al. [33] of 2.2F 0.1 AM (for a VO of2
Table 1
Changes in cytochrome concentrations under normal conditions upon
anoxia and their P50s for a mean cell concentration of 2.6F 0.2	 107
cellsml 1
Cytochrome Changes in concentration (nM) P50 (AM)
bH  16.7F 2.3 1.3F 0.5
c  40.2F 3.6 2.5F 0.6
aa3  9.8F 1.2 4.6F 1.016.6F 1.2 AMmin 1) with cardiac myocytes. Further dis-
cussion of the results of these experiments is given in
Section 4.
3.3. Mitochondrial inhibitors
In order to verify the response of the system to changes
in mitochondrial respiration via the cytochrome redox
states, various known inhibitors were added to cells in the
closed chamber, keeping all other experimental conditions
as previously described. In each case the concentration of
inhibitor used was the minimum required to produce the
maximum response in terms of cytochrome redox changes.
The implications of these findings are discussed in further
detail in Section 4.
3.3.1. Rotenone
On addition of 0.25 AM rotenone (Sigma), all of the
cytochromes undergo an immediate oxidation, as shown in
Fig. 5A (the arrow indicates the addition of rotenone at 50
AM O2), with a corresponding decrease in VO2. Rotenone
has been shown to be specific for inhibition of complex I
only at stoichiometric concentrations [34]. The observed
oxidation is thus due to a shift in the redox steady-state
caused by a decrease in electron flux downstream of
complex I. Table 2 gives the concentration changes for each
cytochrome after addition of rotenone, for a cell concentra-
tion of 2.9F 0.1	107 cellsml 1 (n = 3). Subsequent to the
addition of the inhibitor, 250 AM of potassium cyanide
(KCN) (Sigma) was added to the chamber to inhibit
respiration completely. The remaining non-mitochondrial
consumption of O2 was used to calculate the percentage
inhibition of mitochondrial VO2 due to the addition of
rotenone, found to be 95.2F 2.9%. The residual O2 con-
sumption was 1.7F 0.1 AMmin 1.
3.3.2. Myxothiazol
Myxothiazol inhibits at the level of the bc1 complex at
the proximal Qo site, the site of ubiquinone oxidation [35].
The effect of adding 1 AM of myxothiazol (Sigma) to the
cells (at 62 AM O2) is shown in Fig. 5B. According to the
binding site of myxothiazol, one would expect an oxidation
of cytochrome bH, but instead a slow reduction was ob-
served. This effect is suggested to be due to a leak of
electrons from semiquinone at the Qo site [36]. The con-
centration changes are given in Table 2 for a cell density of
2.6F 0.2	 107 cellsml 1 (n = 4). Mitochondrial respira-
tion was inhibited by 95.5F 1.4%, as determined by the
further addition of 250 AM of KCN. In this case the residual
O2 consumption was 2.1F 0.8 AMmin 1.
3.3.3. Antimycin A
Antimycin A is a complex III inhibitor, blocking electron
flow at the Qi site [37], the site of ubiquinone reduction,
downstream of the b cytochromes. Fig. 5C demonstrates
how the addition (at 48 AM O2) of 0.5 AM of antimycin A
Fig. 5. Effect of various mitochondrial inhibitors on cytochrome redox states. Typical changes in cytochromes bH (closed circles), c (open squares) and aa3
(closed triangles) are displayed against time following the addition (indicated by the arrows) of 0.25 AM of rotenone at an [O2] of 50 AM (A), 1 AM of
myxothiazol at an [O2] of 62 AM (B), 0.5 AM of antimycin A at an [O2] of 48 AM (C) and 250 AM of KCN at an [O2] of 62 AM (D).
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and an oxidation in both cytochromes c and aa3. Table 2
gives the changes in cytochrome concentrations on addition
of the inhibitor for a cell concentration of 2.8F 0.6	 107
cellsml 1 (n= 3). The percentage inhibition of respiration
was 98.9F 0.8%, determined by adding 250 AM of KCN as
described above, with a residual O2 consumption of
2.9F 0.4 AMmin 1.Table 2
Changes in cytochrome concentrations on addition of mitochondrial
inhibitors
Inhibitor [Cells]	
107ml 1
D[bH] (nM) D[c] (nM) D[aa3] (nM)
Rotenone 2.9F 0.1 2.8F 0.7 16.8F 0.7 4.4F 0.1
Myxothiazol 2.6F 0.2  6.7F 0.7 20.7F 1.3 4.4F 0.8
Antimycin 2.8F 0.6  8.4F 0.9 19.5F 0.8 3.1F 0.7
KCN 3.2F 0.3  6.6F 0.7  34.4F 1.3  7.7F 1.3
For the given cell concentration the changes in cytochrome concentrations
on addition of rotenone (0.25 AM), myxothiazol (1 AM), antimycin A (0.5
AM) and KCN (250 AM) are shown.3.3.4. Cyanide
Fig. 5D shows the effects on the cytochrome redox states
of the addition of 250 AM of KCN (at 62 AM O2), which
inhibits at the level of complex IV. All three cytochromes
became reduced on addition of KCN, concomitant with a
block of electron flow at the O2 binding site. The changes in
concentration are given in Table 2, for a cell concentration
of 3.2F 0.3	 107 cellsml 1 (n = 3). The inhibition of
respiration was in this case assumed to be maximal, since
further addition of KCN did not decrease VO2, giving a
residual O2 consumption of 2.0F 0.3 AMmin 1.
3.3.5. NO donor
To demonstrate the ability of our system to study the
effects of NO on the parameters of cellular respiration DEA-
NO (Alexis Chemicals), a short-lived NO donor with a half-
life of 2 min at pH 7.4 and 37 jC [38] was used. A
concentration of 5 AM of the donor was added to the closed
chamber during cellular respiration at an [O2] of 100 AM.
Fig. 6A shows the typical reduction of the cytochromes on
Fig. 6. Effect of inhibition with DEA-NO on cytochrome redox states.
Typical changes in cytochromes bH (closed circles), c (open squares) and
aa3 (closed triangles) (A), the corresponding VO2 (B) and the release of NO
measured by the ISO-NOP electrode (C) following the addition of 5 AM of
DEA-NO at an [O2] of 100 AM are all displayed against [O2]. In each panel
the arrow and the dashed line indicate the addition of DEA-NO.
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in VO2 and the release of NO displayed in Fig. 6B and C,
respectively. The peak concentration of NO measured in the
cells was 4.4F 0.2 AM (n= 3). It is known that NO released
from NO donors is degraded by the autoxidation of NO to
nitrite, the extent of which is proportional to O2 concentra-
tion [39]. In characterising the release of NO from DEA-NO
in the absence of cells, therefore, the [O2] was first reduced
to 100 AM by bubbling with nitrogen prior to addition of the
donor. Since the NO release by DEA-NO is also pH-
dependent [38], the measurement was carried out in the
supernatant of control cells, collected subsequent to their
measurement in the chamber, in which the pH was 7.2. The
peak NO release by 5 AM DEA-NO was found to be
6.6F 0.3 AM (n = 3), approximately 40% higher than that
measured in fresh medium at pH 7.4.
Fig. 6A and C shows that the sudden release of NO on
addition of DEA-NO is accompanied by a sharp inhibition of
the cytochromes, and the slower degradation of NO is
matched by the gradual recovery of their redox states to-
wards baseline. For a cell concentration of 2.0F 0.1	107
cellsml 1 the inhibition of VO2 by 5 AM DEA-NO was
95.2F 1.3%, whereas for cytochromes c and aa3 it was
87.4F 2.0% and 76.1F 2.6%, respectively (n= 3). Unlike
cytochromes c and aa3, the redox state of cytochrome bH does
not fully recover from inhibition, remaining partially reduced
until anoxia whereupon its final reduction is submaximal
compared to controls. The reason for this observation has yet
to be elucidated.4. Discussion
We have developed a novel optical system for studying
the redox behaviour of respiratory complexes in the ETC
which, to our knowledge, has not previously been applied to
intact cells. The determination of redox-dependent changes
in cytochrome concentrations is based upon on an algorithm
that assumes changes in light attenuation are dominated by
changes in absorption, and that scattering changes are
negligible. With the optical arrangement selected, we saw
no evidence for the scattering changes upon anoxia that
have been reported elsewhere. This confirms the validity of
the algorithm. Furthermore, since we have measured the
optical pathlength through the cells for the chosen range of
cell concentration, we are able to quantify the changes in
cytochrome redox states during respiration as real (absolute)
concentration changes. To improve the accuracy of our
measurements, we have rigorously applied corrections to
account for such factors as the finite time response of the
Clark electrode and the background O2 flux in the absence
of cells.
Using the VLS system described here, we first charac-
terised cellular respiration in the Jurkat cell line of human
leukocytes in the absence of respiratory inhibitors. As
shown in Fig. 4B, it is clear that cytochrome c starts to
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cytochrome c, whilst VO2 is still maximal, has been noted
by others both in cells [40] and mitochondria, the latter of
which was associated with changes in pH of the suspension
medium [9]. Chance [41] saw no early reduction in
cytochrome c in yeast, and explained this observation by
others as due to O2 gradients in cells that have aggregated,
or a spectroscopic interference from the deoxygenation of
haemoglobin.
Cellular respiration was characterised by the changes in
cytochrome concentrations at anoxia and the P50s for VO2
and the cytochromes. Values of P50 for VO2 below 1 AM O2
have been obtained for cell concentrations < 106cellsml 1,
the increase in P50 with cell concentration being explained,
in part, by the intracellular O2 gradient [42]. In a study using
isolated mitochondria, Gnaiger et al. [43] observed errone-
ously high P50s for VO2 when the maximal VO2 was greater
than 30 AMmin 1. We found that cell concentrations below
2.0	 107 cellsml 1 did not give a sufficient signal-to-noise
ratio to determine cytochrome concentrations accurately. In
our experiments, therefore, the average cell concentration
was 2.8F 0.3	 107 cellsml 1 (n= 29), with a maximal VO2
of 28.4F 2.4 AMmin 1. Moreover, in the range 2–3	 107
cellsml 1, we observed no correlation between cell con-
centration and P50.
Experiments with mitochondrial inhibitors have demon-
strated that the system is able to monitor cytochrome redox
changes according to the site of mitochondrial inhibition,
indicating that the measured absorption changes are suffi-
ciently specific to allow decomposition of the three cyto-
chrome spectra by our algorithm. Experiments with the
short-lived NO donor DEA-NO established the ability of
the system to observe the reversibility of inhibition of
cytochrome c oxidase, and hence cellular respiration, whilst
simultaneously monitoring NO release from the donor.
The addition of rotenone should enable us to estimate the
ratio of oxidised to reduced cytochromes during the steady-
state of electron transport, assuming total inhibition of
complex I and hence complete oxidation of the downstream
cytochromes. Under our experimental conditions, we found
that cytochromes aa3 are approximately 31% reduced dur-
ing steady-state respiration, in agreement with the findings
of others in mammalian mitochondria [10]. However, cyto-
chrome bH was only 14% reduced, an observation that
appears to conflict with the concept that cytochromes closer
to the oxidising (O2) end of the ETC will be more oxidised
than those at the reducing end. Whether this unexpected
finding could be attributed, at least in part, to the formation
of reactive oxygen species, observed following treatment
with rotenone [34], has yet to be determined.
We noted that with the addition of the complex III
inhibitor myxothiazol there was a gradual reduction in bH
continuing beyond 30 s after addition (Fig. 5B). Antimycin
A, however, produced a rapid reduction in cytochrome bH
that reached a stable level within 5–10 s (Fig. 5C). Whilst
this difference could be related to the time taken for theinhibitors to bind to their respective sites, this observation
could also reflect the gradual reduction of cytochrome bH
due to a leak of electrons from the Qo site with myx-
othiazol, compared to the immediate downstream inhibi-
tion, and hence reduction of bH, by antimycin A. Both
inhibitors produced a sub-maximal reduction of cyto-
chrome bH compared to controls, which could be a
consequence of an equilibration of electron transfer be-
tween bH and the ubiquinone pool [36]. This bypass
reaction of electrons has been associated with superoxide
production after inhibition of mitochondria with antimycin
[44] and in purified bc1 complex [45].
Inhibition of the terminal enzyme in the ETC should
result in the maximal reduction of upstream cytochromes.
On addition of KCN, however, the reduction of cyto-
chromes aa3 was only 79% of that at anoxia. This has also
been observed in mitochondria [10] and is due to the fact
that KCN binds to cytochrome a3 mainly in its oxidised
form. Hence, only the subsequent reduction in cytochrome
a, which is known to contribute 80–90% of the aa3 signal
[10], will account for the change in the measured spectrum.
It should be noted, however, that spectral changes in the
region over which the aa3 fitting is performed will contain a
small contribution due to KCN binding to oxidised cyto-
chrome a3 that will not be accounted for by the current
fitting. These changes include a slight shift (f 5 nm) in the
difference peak to shorter wavelengths and the appearance
of a shoulder on the short wavelength side of the peak [28].
In summary, our system based on VLS is capable of
monitoring cytochrome redox states in mammalian cells
and the effects of NO on parameters of cellular respiration.
It is important to emphasise the value of monitoring VO2
and the cytochrome redox states simultaneously, as we
have done in intact cells, when studying the modulation by
NO of the apparent affinity of cytochrome c oxidase for
O2. This novel combination of methodologies that we have
now described will doubtless allow us to answer many
physiologically relevant questions relating to the role of
endogenous NO in the control of cell respiration, particu-
larly at the low concentrations produced by the constitutive
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